首页> 外文期刊>Liver research. >The alteration of immune cells in the pathogenesis of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
【24h】

The alteration of immune cells in the pathogenesis of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

机译:非酒精脂肪肝疾病和非酒精脂肪肝炎发病机制中免疫细胞的改变

获取原文
           

摘要

The prevalence of non-alcoholic fatty liver disease (NAFLD) increases rapidly in recent decades. NAFLD has become a major public health problem in China and the whole world, and it is considered as the main cause for the chronic liver diseases. However, there is still not specific and effective treatment for non-alcoholic steatohepatitis (NASH), the advanced form of NAFLD. The inflammation in the liver is the hallmark of NASH. Actually, the dysregulation of immune cells happened in the early stage of NAFLD. Targeting immune cells in the liver may represent one of the effective ways for NASH treatment. A better understanding of the change of immune cells in the pathogenesis of NAFLD will be very helpful for developing new treatments for NAFLD and NASH. Here we summarized how the immune cells were affected in different stages of NAFLD and how these immune cells contributed to the development of NAFLD.
机译:近几十年来,非酒精性脂肪肝疾病(NAFLD)的患病率迅速增加。 NAFLD已成为中国和全球的主要公共卫生问题,它被认为是慢性肝病的主要原因。然而,对非酒精脱脂性炎(NASH),NAFLD的先进形式仍然没有特异性和有效的治疗。肝脏中的炎症是纳什的标志。实际上,在NAFLD的早期阶段发生了免疫细胞的失调。靶向肝脏中的免疫细胞可能代表纳什处理的有效方法之一。更好地了解在NAFLD发病机制中的免疫细胞变化对于开发NAFLD和NASH的新治疗非常有帮助。在这里,我们总结了在NAFLD的不同阶段的影响以及这些免疫细胞如何导致NAFLD的发育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号